Journal
NEUROBIOLOGY OF AGING
Volume 35, Issue 6, Pages -Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2013.12.007
Keywords
Alzheimer disease; Age related macular degeneration; Genetic association; Gene-based test; Pathway analysis
Categories
Funding
- National Institutes of Health [R01-AG025259, PG30-AG13846, U01-AG032984, R01-EY0144581]
- Research to Prevent Blindness, Inc NY
- Department of Ophthalmology and Visual Sciences, University of Utah
- Edward and Della Thome Memorial Foundation
Ask authors/readers for more resources
Several lines of inquiry point to overlapping molecular mechanisms between late-onset Alzheimer disease (AD) and age-related macular degeneration (AMD). We evaluated summarized results from large genome-wide association studies for AD and AMD to test the hypothesis that AD susceptibility loci are also associated with AMD. We observed association of both disorders with genes in a region of chromosome 7, including PILRA and ZCWPW1 (peak AMD SNP rs7792525, minor allele frequency [MAF] 19%, odds ratio [OR] 1.14, p 2.34 x 10(-6)), and with ABCA7 (peak AMD SNP rs3752228, MAF = 0.054, OR 1.22, p 0.00012). Next, we evaluated association of AMD with genes in AD-related pathways identified by canonical pathway analysis of AD-associated genes. Significant associations were observed with multiple previously identified AMD risk loci and 2 novel genes: HGS (peak SNP rs8070488, MAF 0.23, OR 0.91, p 7.52 = 10 x 5), which plays a role in the clathrin-mediated endocytosis signaling pathway, and TNF (peak SNP rs2071590, MAF 0.34, OR 0.89, p 1.17 = 10 x 5), which is a member of the atherosclerosis signaling and the LXR/ RXR activation pathways. Our results suggest that AMD and AD share genetic mechanisms. (C) 2014 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available